CROWN 2018 is an elite gathering of clinical decision-makers ready to learn, network and engage on topics critical to the effective development, execution and management of clinical trials
99 South 17th Street at Liberty Place8th CROWN Congress Philadelphia PA
As a clinical trial professional, we understand your positive impact on trial development, planning, execution, quality, and data generation. This year’s CROWN Congress will review the clinical trial landscape, providing in-depth sessions on the approaches, innovations, and collaborations that are accelerating clinical trials.
Now in its 8th consecutive year, the CROWN Congress will highlight additional areas such as clinical risk management, outsourcing strategies, operational metrics, risk-based monitoring, patient engagement, and more!
Start your year off right by receiving the latest strategies, trends, tools and technologies needed to advance clinical trials, and make the connections needed to position your company for success in 2019.
Stephen Brannan, M.D., Chief Medical Officer, KARUNA PHARMACEUTICALS
Randy Krauss, Head Clinical Performance and Analytics, MERCK
Costa Panagos, President, Clinical Operations, IQVIA
OPERATIONAL EXCELLENCE TRACK CHAIR
Stella Stergiopoulos, Senior Project Manager, TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT
TECHNOLOGY AND INNOVATION TRACK CHAIR
Joshua Rubin, J.D., MBA, MPP, MPH, Program Officer for Learning Health System Initiatives, UNIVERSITY OF MICHIGAN MEDICAL SCHOOL DEPARTMENT OF LEARNING HEALTH SCIENCES
PARTNERSHIPS WITH STAKEHOLDERS TRACK
Leesa Gentry, Senior Vice President, Infectious Disease, EVOTEC (US), INC.
"As a writer who covers the clinical space, access to executives at pharma companies is vital to my job. The quality of the topics and speakers at the CROWN Congress makes this a "must-attend" event for me. The networking that takes place here is very valuable."
—Ed Miseta, Chief Editor, CLINICAL LEADER
“I connected with other players in the industry and shared ideas and discussed the state of clinical operations, to better understand what our companies are currently doing.”
—Ernestine Tucker, Senior Manager, Clinical Research, CHUGAI PHARMA USA
“Congratulations on a wonderful congress, the intimate and still vibrant atmosphere was great.”
—Director, Clinical Compliance, Process and Procedures, REGENERON PHARMACEUTICALS, INC.
“Usually I’m bored at conferences and don’t learn anything new, but almost every session provided me with new knowledge!”
—Principal, Biopharma QA and Outsourcing Consultants